top of page
Profile-side-by-side.jpg

Enhancing Facial Harmony in GLP-1 Medication Users: Insights from Dr Lorencs New Study

  • Apr 10
  • 3 min read

Weight loss is often celebrated for its health benefits, but for many people using glucagon-like peptide-1 receptor agonists (GLP-1 RAs), it can bring unexpected changes to facial appearance. These medications, popular for managing weight, sometimes cause facial volume loss, wrinkles, and sagging skin. This can leave users feeling less confident and dissatisfied with their appearance.


Dr. Z Paul Lorenc and his team recently published a groundbreaking study in the Aesthetic Surgery Journal that explores a promising treatment to address these concerns. Their research focuses on a combined regimen using poly-L-lactic acid (PLLA) and hyaluronic acid (HA) fillers to restore facial harmony and improve skin quality in GLP-1 medication users.


This blog post breaks down the key findings of this study and explains how this treatment can help those affected regain a youthful, balanced look.




Understanding the Facial Changes from GLP-1 Medication


GLP-1 receptor agonists have become widely used for weight management due to their effectiveness. However, rapid or significant weight loss often leads to a loss of facial fat and volume. This can cause:


  • Deepening of cheek wrinkles

  • Midface contour deficiencies

  • Sagging skin that creates an aged or gaunt appearance


These changes affect not only physical appearance but also self-esteem and satisfaction with one’s image.


Dr. Lorenc’s study highlights the importance of addressing these side effects to improve overall well-being for GLP-1 users.


The Treatment Regimen: Combining PLLA and Hyaluronic Acid Fillers


The study tested a combined approach using:


  • Poly-L-lactic acid (PLLA-SCA): A biostimulatory filler that encourages collagen production, improving skin texture and volume over time.

  • Two types of hyaluronic acid fillers (HA-LYF and HA-CON): These provide immediate volume restoration and contour correction in the midface area.


Participants received 2 to 3 sessions of PLLA-SCA and 1 to 2 sessions of HA fillers. Follow-ups were conducted for up to 9 months after the last PLLA treatment to assess long-term effects.


Key Findings from the Study


The results showed significant improvements in facial appearance and skin quality among the 41 subjects who had experienced weight loss due to GLP-1 therapy:


  • Facial volume and contour: The combined treatment restored midface volume and corrected contour deficiencies, resulting in a more balanced and youthful look.

  • Skin quality: Objective measurements showed enhanced skin texture and elasticity, attributed to the collagen-stimulating effects of PLLA.

  • Patient satisfaction: Self-assessment questionnaires revealed high satisfaction rates, with many participants reporting improved confidence and self-image.

  • Safety: The treatment was well tolerated, with no serious adverse events reported during the study period.


These findings suggest that this combined filler regimen offers a safe and effective way to counteract the facial aging effects linked to GLP-1 medication use.


Practical Considerations for Patients and Providers


For those considering this treatment, here are some important points:


  • Treatment plan: Multiple sessions are necessary to achieve optimal results, with a combination of immediate and long-term effects.

  • Customization: The choice between HA-LYF and HA-CON fillers depends on individual facial anatomy and specific contour needs.

  • Follow-up: Regular follow-ups ensure the treatment progresses well and any adjustments can be made.

  • Consultation: A thorough consultation with a qualified aesthetic specialist is essential to tailor the approach and set realistic expectations.


Where to Find the Full Study


For readers interested in the detailed scientific data and methodology, the full study is available open access in the Aesthetic Surgery Journal:



 
 
 

Comments


bottom of page